Stay updated on Safety of CAN04 and Pembrolizumab in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Safety of CAN04 and Pembrolizumab in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of CAN04 and Pembrolizumab in Solid Tumors Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    No significant changes detected.
    Difference
    0.5%
    Check dated 2025-10-13T07:28:15.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    Core content updated with a government-operating-status notice and a version upgrade to v3.2.0, replacing the previous v3.1.0.
    Difference
    3%
    Check dated 2025-10-06T04:49:57.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    - Removed a specific resource topic (Head and neck squamous cell carcinoma) from Genetic and Rare Diseases Information Center resources. - Updated the revision version to v3.1.0.
    Difference
    0.9%
    Check dated 2025-09-29T02:55:19.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.0.2 (replacing v3.0.1), indicating an update. The Back to Top link has been removed, a minor UI change.
    Difference
    0.6%
    Check dated 2025-09-14T18:51:34.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.2%
    Check dated 2025-09-07T13:24:26.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    The web page has been updated to include new information on various types of cancers, including lung cancer and head and neck squamous cell carcinoma, while removing references to certain cancer types and treatments. Additionally, the facility name and location details have been added.
    Difference
    6%
    Check dated 2025-08-31T11:16:15.000Z thumbnail image

Stay in the know with updates to Safety of CAN04 and Pembrolizumab in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of CAN04 and Pembrolizumab in Solid Tumors Clinical Trial page.